Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
CURRENT ASSETS:
Cash and cash equivalents	$ 2,304.2	$ 1,682.9
Short-term investments	548.8	502.6
Marketable equity securities	26.1	25.5
Accounts receivable—net	1,087.2	1,261.7
Inventory	302.7	264.6
Prepaid expenses and other current assets	89.7	73.1
Total current assets	4,358.7	3,810.4
LONG-TERM INVESTMENTS	15.6	45.5
PROPERTY AND EQUIPMENT—NET	917.4	898.5
DEFERRED CONTRACT COSTS	536.9	518.2
DEFERRED TAX ASSETS	649.6	569.4
GOODWILL	127.8	128.0
OTHER INTANGIBLE ASSETS—NET	51.1	56.0
OTHER ASSETS	175.2	202.0
TOTAL ASSETS	6,832.3	6,228.0
CURRENT LIABILITIES:
Accounts payable	238.4	243.4
Accrued liabilities	346.7	266.3
Accrued payroll and compensation	213.4	219.4
Deferred revenue	2,463.3	2,349.3
Total current liabilities	3,261.8	3,078.4
DEFERRED REVENUE	2,417.6	2,291.0
INCOME TAX LIABILITIES	70.5	67.8
LONG-TERM DEBT	990.9	990.4
OTHER LIABILITIES	80.1	82.0
Total liabilities	6,820.9	6,509.6
COMMITMENTS AND CONTINGENCIES (Note 11)
STOCKHOLDERS’ EQUITY (DEFICIT):
Common stock, $0.001 par value—1,500.0 shares authorized; 784.4 and 781.5 shares issued and outstanding on March 31, 2023 and December 31, 2022, respectively	0.8	0.8
Additional paid-in capital	1,327.4	1,284.2
Accumulated other comprehensive loss	(18.1)	(20.2)
Accumulated deficit	(1,298.7)	(1,546.4)
Total stockholders’ equity (deficit)	11.4	(281.6)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	$ 6,832.3	$ 6,228.0